Skip to main content

Research Repository

Advanced Search

Pathogenesis and management of gastroesophageal reflux disease-associated cough: a narrative review

Zhang, Li; Aierken, Alimire; Zhang, Mengru; Qiu, Zhongmin

Authors

Li Zhang

Alimire Aierken

Mengru Zhang

Zhongmin Qiu



Abstract

Background and Objective: Gastroesophageal reflux disease (GERD)-associated cough is defined as a special GERD with a predominant cough symptom and is a common cause of chronic cough. This review summarizes our current understanding on the pathogenesis and management of GERD-associated cough. Methods: Main literatures on the pathogenesis and management of GERD-associated cough were reviewed and our understandings derived from the published studies were showed then. Key Content and Findings: Although esophageal-tracheobronchial reflex mainly underlies the pathogenesis of GERD-associated cough, its counterpart-tracheobronchial-esophageal reflex might exist and initiate the cough due to reflux induced by upper respiratory tract infection through the signaling of transient receptor potential vanilloid 1 linking airway and esophagus. The presence of reflux-associated symptoms such as regurgitation and heartburn along with coughing suggests an association between cough and GERD, which is supported by the objective evidence of abnormal reflux as detected by reflux monitoring. Although there is no general consensus, esophageal reflux monitoring provides the main diagnostic criteria for GERD-associated cough. Despite that acid exposure time and symptom associated probability are useful and mostly employed reflux diagnostic criteria, they are imperfect and far from being the gold standard. Acid suppressive therapy has long been recommended as the first choice for GERD-associated cough. However, the overall benefits of proton pump inhibitors have been controversial and need to be further assessed, especially in patients with cough due to non-acid reflux. Neuromodulators have demonstrated potential therapeutic effects for refractory GERD-associated cough, for which anti-reflux surgery may also be a promising treatment option. Conclusions: Tracheobronchial-esophageal reflex might initiate reflux-induced cough provoked by the upper respiratory tract infection. It is necessary to optimize the current standards and to explore new criteria with higher diagnostic potency. Acid suppressive therapy is the first choice for GERD-associated cough, followed by neuromodulators and anti-reflux surgery for refractory GERD-associated cough.

Citation

Zhang, L., Aierken, A., Zhang, M., & Qiu, Z. (2023). Pathogenesis and management of gastroesophageal reflux disease-associated cough: a narrative review. Journal of thoracic disease, 15(4), 2314-2323. https://doi.org/10.21037/jtd-22-1757

Journal Article Type Review
Acceptance Date Apr 13, 2023
Online Publication Date Aug 28, 2023
Publication Date Apr 1, 2023
Deposit Date Jun 17, 2025
Publicly Available Date Jun 17, 2025
Journal Journal of Thoracic Disease
Print ISSN 2072-1439
Peer Reviewed Peer Reviewed
Volume 15
Issue 4
Pages 2314-2323
DOI https://doi.org/10.21037/jtd-22-1757
Keywords Anti-reflux treatment; chronic cough; gastroesophageal reflux; reflux monitoring
Public URL https://hull-repository.worktribe.com/output/5239781

Files

Published article (637 Kb)
PDF

Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright Statement
© Journal of Thoracic Disease.
This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.




You might also like



Downloadable Citations